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http:WHAT THIS PAPER ADDS
In this study peri-operative variables that affected outcome after ruptured abdominal aneurysm repair were
analysed. The added value of this study is the comparison of independently signiﬁcant variables between
endovascular and open surgery, demonstrating that preoperative risk factors inﬂuence outcome differently,
depending on the type of repair. This information could promote a treatment selection process, based on risk
estimates that are repair-dependent.Objective/background: Endovascular aneurysm repair (EVAR) for ruptured abdominal aortic aneurysm (rAAA)
has faced resistance owing to the marginal evidence of beneﬁt over open surgical repair (OSR). This study aims to
determine the impact of treatment modality on early mortality after rAAA, and to assess differences in
postoperative complications and long-term survival.
Methods: Patients treated between January 2000 and June 2013 were identiﬁed. The primary endpoint was early
mortality. Secondary endpoints were postoperative complications and long-term survival. Independent risk
factors for early mortality were calculated using multivariate logistic regression. Survival estimates were obtained
by means of KaplaneMeier curves.
Results: Two hundred and twenty-one patients were treated (age 72 8 years, 90% male), 83 (38%) by EVAR and
138 (62%) by OSR. There were no differences between groups at the time of admission. Early mortality was
signiﬁcantly lower for EVAR compared with OSR (odds ratio [OR]: 0.45, 95% conﬁdence interval [CI]: 0.21e0.97).
Similarly, EVAR was associated with a threefold risk reduction in major complications (OR: 0.33, 95%CI: 0.15e
0.71). Hemoglobin level <11 mg/dL was predictive of early death for patients in both groups. Age greater than 75
years and the presence of shock were signiﬁcant risk factors for early death after OSR, but not after EVAR. The
early survival beneﬁt of EVAR over OSR persisted for up to 3 years.
Conclusion: This study shows an early mortality beneﬁt after EVAR, which persists over the mid-term. It also
suggests different prognostic signiﬁcance for preoperative variables according to the type of repair. Age and the
presence of shock were risk factors for early death after OSR, while hemoglobin level on admission was a risk
factor for both groups. This information may contribute to repair-speciﬁc risk prediction and improved patient
selection.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Since the introduction of endovascular aneurysm repair
(EVAR) in 1991 by Volodos et al.1 and Parodi et al.,2 the use
of this less invasive treatment for infra-renal aortic aneu-
rysms has expanded signiﬁcantly. Nowadays, >60e70% ofrresponding author. F.M. Bastos Goncalves, Department of Vascular
, Erasmus University Medical Centre, Gravendijkwal 230, 3015 CE
am, The Netherlands.
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//dx.doi.org/10.1016/j.ejvs.2014.01.016all elective abdominal aortic aneurysm (AAA) repairs are
performed with EVAR.3,4 This is not the case for ruptured
AAA (rAAA), for which the use of EVAR has not yet achieved
generalized acceptance.5,6 In general, rAAA are frequently
fatal with a mortality of up to 80%,7 but patients surviving
until they receive hospital care, might expect to beneﬁt
from a minimally invasive technique.
For elective surgery, randomized trials have demon-
strated a nearly uniform threefold reduction in peri-
operative mortality and prolonged survival beneﬁt for
EVAR over open surgical repair (OSR), which is maintained
for at least 2 years.8,9 These results, also conﬁrmed by large
registries and national audits,10 have justiﬁed a shift
480 G.C.I. von Meijenfeldt et al.towards a preferential use of EVAR. For rupture, however,
evidence of a similar advantage is still lacking.
The aim of this study was to determine the impact of
treatment modality on early mortality after rAAA repair, and
to evaluate the differences in the prognostic capacity of
preoperative variables in determining early survival for
EVAR and OSR. Additionally, we investigated the differences
in major postoperative complications and assessed any
survival advantage related to treatment modality during
follow-up.METHODS
The study complied with the Declaration of Helsinki. Ac-
cording to our institutional guidelines, no formal ethical
approval was required.Patients
The study population consisted of all consecutive patients
who underwent AAA repair between January 2000 and June
2013 at a single, tertiary institution. For this study, only
patients with conﬁrmed rAAA were included. Some of these
patients have previously been included in a published 20-
year overview of institutional trends in the management
of rAAA.7 Patients with infected aneurysms and those
having had prior aneurysm repair were excluded from the
analysis.Data collection
All possible operation codes and surgical reports were
retrospectively retrieved, and hospital charts and computed
tomography angiographies (CTAs) were checked for the
presence of rupture. If conﬁrmed, patient demographics,
clinical baseline characteristics, intraoperative details, and
clinical and laboratory outcome were obtained. Baseline
characteristics on admission included age, gender, state of
consciousness, blood pressure, and pulse rate. Duration
from the emergency room (ER) to the operating theatre,
operation duration, body temperature, blood pressure and
pulse rate during operation, type of anesthesia, blood loss,
and usage of blood products and ﬂuids were derived from
operative and anesthesia reports. Laboratory results on
admission were also obtained. Postoperative complications
and events were retrieved from hospital registries. Survival
status and the exact date of death of treated patients were
obtained via the national civil registry.Missing data
Baseline data that were not retrievable were analyzed for
differences between the OSR and EVAR groups. There were
no signiﬁcant differences in the number of missing data in
either group, except for blood loss and the volume of
intraoperative transfusion, owing to a lack of documenta-
tion about minimal blood loss and transfusions needed with
an EVAR procedure. Only variables with <3% missing data
were included in multivariate models.Institutional management of rAAA
The Erasmus University Medical Center is a tertiary teaching
institution with full capacity for endovascular and open
vascular surgery (24 hours a day/7 days a week), serving
about 1.5 million people living in the Rotterdam and sur-
rounding area. Owing to the characteristics of the institu-
tion, a relatively high proportion of AAA repairs are done for
rupture. Although the logistics involved in EVAR have been
adapted and improved over time, the capacity to offer both
treatment options was present throughout the entire study
period. This made EVAR available for any anatomically
suitable patient on any day and at any time. The choice of
treatment is individualized, but preference is generally
given to EVAR in older patients.
If a patient presents at the ER with a suspected rAAA, the
on-call surgical team is informed. On arrival of the patient in
the ER, an ultrasound of the abdominal aorta is done to
conﬁrm the presence of an aortic aneurysm if the patient is
not known to have an AAA. Otherwise, a CTA can be per-
formed immediately. Patients are managed by permissive
hypotension in the ER, and resuscitation is started only if
the patient becomes unconscious.
According to protocol, a multi-slice CT scanner is used for
rAAA CTA. The patient is scanned from nipple to pubic
symphysis with a collimation of 118*0.6, and plain and
contrast series are acquired after administering 120 mL of
Visipaque 320 contrast. Anatomical suitability for EVAR is
determined by the surgeon’s expectations and experience.
In anatomically complex cases, or whenever time allows, a
dedicated post-processing workstation (3Mensio Vascular
4.2 software; 3Mensio Medical Imaging, Bilthoven, the
Netherlands) is available for sizing and planning. After
diagnosis, informed consent is obtained whenever possible.
Aneurysm repair is performed either by consultant
vascular surgeons or by residents during their vascular sub-
specialization under the direct supervision of a consultant
vascular surgeon. For EVAR, repair is performed in the
operating theatre using a mobile C-arm. Preference is given
to local anesthesia for EVAR, although the decision depends
on the individual case.
For OSR, a midline transperitoneal approach is preferred,
and aorto-aortic or aorto-bi-iliac reconstruction is per-
formed depending on the presence of concomitant iliac
aneurysms. Postoperatively, intra-abdominal pressure using
a vesical pressure probe is only checked when there is
clinical suspicion of abdominal compartment syndrome.Deﬁnitions
Rupture was deﬁned by either direct visualization of fresh
blood in the retroperitoneal or peritoneal compartments
during OSR, or visualization of peri-aortic hematoma on the
immediate preoperative CTA.11 Early mortality was deﬁned
by in-hospital mortality or death within 30 days of surgery.
Major complications were deﬁned as one of the following:
respiratory; cardiac; cerebrovascular; renal failure (esti-
mated glomerular ﬁltration rate [eGFR] < 30); abdominal;
wound; bleeding-related; lower limb ischemia; graft-related.
Table 1. Preoperative baseline characteristics on admission.
Variable OSR
n ¼ 138
EVAR
n ¼ 83
p
Age
Mean  SD 71.9  7.8 72.1  8.2 .89
>75 y, n (%) 46 (33) 29 (35) .81
Male gender, n (%) 123 (89) 68 (93) .37
Unconsciousness, n (%) 4 (3) 1 (1) .65
Cardiopulmonary
resuscitation
before OR, n (%)
1 (1) 0 (0) 1
Hemodynamic statusa
Systolic
blood pressure,
mean  SD
114  37 115  37 .81
Diastolic
blood pressure,
mean  SD
69  26 67  21 .55
Heart rate (bpm),
mean  SD
85  22 88  25 .37
Shock index > 1b 31 (24) 29 (36) .05
Hemoglobin (g/dL)
Median (IQR) 11.1
(9.4e12.6)
11.8
(9.6e13.3)
.10
<11, n (%) 60 (46) 31 (42) .59
Coagulation
INR  1.5, n (%)c 33 (28) 24 (33) .52
Platelet count
(103/mL),
median (IQR)a
177
(135e235)
196
(154e256)
.008
eGFR
Median (IQR) 61
(45e77)
63
(46e75)
.96
< 60, n (%) 68 (53) 37 (51) .86
Leukocytes (103/mL),
median (IQR)c
12.0
(9.0e16.3)
12.5
(8.5e16.3)
.69
CRP (mg/dL),
median (IQR)c
11 (5e47) 14 (4e70) .58
Time from ER to OR (mins)d 50 36 .023
Note. OSR ¼ open surgical repair; EVAR ¼ endovascular aneurysm
repair; OR ¼ operating room; BPM ¼ beats per minute;
IQR ¼ interquartile range; INR ¼ international normalized ratio;
eGFR ¼ estimated glomerular ﬁltration rate; CRP ¼ C reactive
protein; ER ¼ emergency room.
a Missing 1e3% of baseline data.
b Heart rate/systolic blood pressure.
c Missing 3e15% of baseline data.
d Missing >15% of baseline data.
European Journal of Vascular and Endovascular Surgery Volume 47 Issue 5 p. 479e486 May/2014 481Endovascular complications and EVAR-related adverse
events were classiﬁed according to the reporting standards
for EVAR by Chaikof et al.12 The shock index was calculated
by dividing the heart rate by systolic blood pressure, and
was calculated from the ﬁrst heart rate and blood pressure
recorded on arrival in the ER.13Endpoints
The primary study endpoint was early mortality. Secondary
endpoints were early major complications and overall sur-
vival during follow-up.Statistical analysis
Categorical variables are presented as counts and percent-
ages, and compared with chi-square tests. Continuous var-
iables are presented as means  standard deviation and
compared with Student t tests; or as median and inter-
quartile range, and compared with ManneWhitney U tests
if the distribution was non-parametric. The inﬂuence of
missing data on results was tested by comparing the
outcome of patients with missing data to those with com-
plete data sets. A logistic regression model was used to
assess the proportional outcome risk associated with EVAR.
Variables associated with 30-day in-hospital mortality were
tested in univariate analysis by type of repair, and signiﬁ-
cant variables were introduced in a multivariate logistic
regression model to determine independent signiﬁcance.
From the beginning of the study period the implementation
of EVAR evolved and the number of patients undergoing
the procedure increased. As a result, the year of operation
was used as a co-variable to adjust for the growth in pa-
tients treated with EVAR every year. A graph of the pro-
portion of the groups per year and the mortality rates per
year of both groups is shown to illustrate the changes in
both groups during the study period. Overall survival during
follow-up was estimated using KaplaneMeier tables, and
survival after EVAR versus open repair was compared using
the log-rank (ManteleCox) statistical test.
RESULTS
From January 2000 to June 2013, 878 patients underwent
AAA repair at our institution. The study sample of rAAA
included 221 patients with a mean age of 72  8 years (90%
of whom were men). Of these 221 patients, 138 were
treated with OSR and 83 with EVAR. The demographics and
clinical characteristics of patients on admission did not
differ signiﬁcantly between groups (Table 1).Intraoperative details
Within the OSR group, 13 (9%) intraoperative deaths
occurred, while in the EVAR group four (5%) deaths
occurred (p ¼ .21; Table 2). Most deaths occurred as a
result of severe hemorrhagic shock. Intraoperative compli-
cations were observed in 15 (11%) and 10 (13%) patients
after OSR and EVAR, respectively (p ¼ .48). These compli-
cations differed signiﬁcantly between groups. Thrombosis
(n ¼ 7) and iatrogenic arterial lesions or dissection (n ¼ 6)
were the most frequent intraoperative complications for
the OSR group; in the EVAR group, the main intraoperative
complications were type I/III endoleaks (n ¼ 6). Large dif-
ferences were observed between the two treatment groups
regarding the duration of operation, estimated intra-
operative blood loss, and the intraoperative consumption of
blood products and ﬂuids (p < .001; Table 2).Early survival
Early death occurred in 55 patients (40%) and 20 patients
(24%) for OSR and EVAR, respectively. After adjusting for
Table 2. Intraoperative characteristics.
Variable OSR EVAR p
Duration of surgery (h), median (IQR)a 3.42 (3.07e4.46) 2.46 (2.20e3.57) <.001
Blood loss (mL), median (IQR)b 4,500 (2,050e8,875) 200 (0e500) <.001
Red blood cell concentrates, median (IQR)b 6 (3e11) 2 (0e4.5) <.001
Plasma units, median (IQR)b 6 (2e10) 0 (0e2) <.001
Platelet units, median (IQR)b 1 (0e5) 0 (0e0) <.001
Crystalloids, median (IQR)b 4,000 (2,500e7,000) 1,500 (1,000e2,125) <.001
Colloids, median (IQR)b 1,500 (1,000e2,000) 500 (0e1,000) <.001
Body temperature at end of surgery, C, median
(IQR)b
35.9 (35.0e36.5) 36.00 (35.50e36.25) .21
Intraoperative death, n (%)a 13 (9) 4 (5) .21
Intraoperative complications, n (%)a 15 (11) 12 (14) .48
Endoleaks (type I/III), n (%) d 6 (7)
Graft occlusion 2 (1) 1 (1)
Peripheral embolization/thrombosis 7 (5) 0 (0)
Iatrogenic dissection 3 (2) 0 (0)
Arterial disruption with bleeding 3 (2) 2 (2)
Unintentional renal artery occlusion 0 (0) 2 (2)
Note. OSR ¼ open surgical repair; EVAR ¼ endovascular aneurysm repair; IQR ¼ interquartile range.
a Missing 1e3% of baseline data.
b Missing 3e15% of baseline data.
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status, and year of operation, EVAR was associated with a
twofold risk reduction of early death compared with OSR
(odds ratio [OR]: 0.45; 95% conﬁdence interval [CI]: 0.21e
0.97; Table 3). In multivariate analysis of risk factors for
early mortality (Fig. 1), signiﬁcant differences were
observed between groups. Only a low Hgb level was an
independent risk factor for both types of repair. Being older
than 75 years and the presence of shock were risk factors
for OSR only and not for EVAR. Univariate analysis sug-
gested coagulopathy on admission as a risk factor for EVAR
(OR: 4.60, 95%CI: 1.49e14.18) instead of OSR (OR: 1.69,
95%CI: 0.79e3.66), but the high number of missing values
(12%) did not allow for inclusion of this variable in the
multivariate model. Type of anesthesia (local vs. general)
had no effect on mortality for EVAR patients (OR: 1.19, 95%
CI: 0.67e2.04). Fig. 2 shows the proportion per year ofTable 3. Thirty-day/in-hospital outcome after ruptured abdominal
aortic aneurysm repair.
Variable OSR EVAR ORa 95%CI
Mortality 55 (40) 20 (24) 0.45 0.21e0.97
Major complications 95 (76) 46 (58) 0.33 0.15e0.71
Systemic complications 80 (64) 42 (53) 0.69 0.34e1.38
Local complications 38 (30) 15 (19) 0.37 0.16e0.83
Fatal complications 37 (30) 13 (16) 0.39 0.17e0.90
Multiple complications 52 (42) 21 (27) 0.53 0.26e1.08
Note. ORs are given for EVAR compared with OSR. Signiﬁcant
values are presented in bold. OSR ¼ open surgical repair;
EVAR ¼ endovascular aneurysm repair; OR ¼ odds ratio;
CI ¼ conﬁdence interval.
a Logistic regression is performed for each outcome measure,
adjusting for age, gender, estimated glomerular ﬁltration rate,
preoperative hemoglobin level, hemodynamic status (shock index),
and year of operation.EVAR- or OSR-treated patients, as well as the 30-day mor-
tality per year per treatment.Major postoperative complications
Median stay in the intensive care unit (ICU) was 4 (1e11)
days for OSR and 1 (1e5) days for EVAR (p ¼ .001). Median
hospital stay was 14 (6e33) days for OSR and 8.5 (4e21)
days for EVAR (p ¼ .001). More major complications
occurred after OSR than after EVAR (76% vs. 58%, p¼ .007).
Furthermore, OSR patients were more likely to suffer from
more than one complication (42% vs. 24%, p ¼ .047) and
have more frequent fatal complications (30% vs. 16%,
p ¼ .033). The distribution of complications is shown in
Table 4. More abdominal, wound, and bleeding complica-
tions occurred after OSR, and more graft-related problems
occurred after EVAR. Compared with OSR, EVAR was asso-
ciated with a threefold risk reduction for major complica-
tions (OR: 0.33, 95%CI: 0.15e0.71), after adjusting for age,
gender, Hgb, eGFR, hemodynamic status on admission, and
year of surgery (Table 3).Late survival
The survival beneﬁt after EVAR on early outcome was
maintained during the mid-term follow-up. The estimated
survival after 2 years was 52% for OSR versus 65% for EVAR
(p < .001; Fig. 3). After 3 years, the survival beneﬁt after
treatment with EVAR was no longer present.DISCUSSION
In this study, EVAR was associated with a twofold reduction
in early mortality after rAAA, after correcting for possible
confounders. This beneﬁt persisted for up to 3 years after
the index event. Moreover, risk factors for early mortality
varied in type and importance according to which
Figure 1. Multivariate logistic regression analysis of risk factors for early mortality, by type of repair (only including variables with <3%
missing data). Note. eGFR ¼ estimated glomerular ﬁltration rate; OSR ¼ open surgical repair; EVAR ¼ endovascular aneurysm repair.
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have a potential impact on current clinical practice.
In contrast to elective EVAR, which is widely accepted,
EVAR for rAAA is far from accepted owing to a signiﬁcant
lack of level A evidence.5,6 To date, only two randomized
controlled trials have been published on the subject. The
Nottingham trial, which was only a pilot study, had difﬁ-
culties with enrollment and was not able to show any dif-
ferences in early mortality or complications. Recently, the
results of the AJAX trial have been published.14,15 In this
study, no difference in 30-day mortality and severe com-
plications between EVAR and OSR were found. This could be
explained, in part, by the unexpectedly good results from
OSR, arguably difﬁcult to achieve in most settings. With
regard to the secondary endpoints of the AJAX study, EVAR
generally performed better: mean ICU stay, mean hospital
stay, mean blood loss, and the need for mechanical venti-
lation all favored the EVAR group. Both of the aforemen-
tioned studies were limited by low inclusion rates, which
may result in signiﬁcant bias, and are both considered to be
underpowered.
Two other randomized trials are still in progress
(IMPROVE16 and ECAR17). While the results of the ECAR trial
are awaited, the IMPROVE investigators recently presented
preliminary data.18 They were able to recruit 613 patients
(about two-thirds of all eligible patients) with a clinical
diagnosis of ruptured aneurysm. Based on intention-to-
treat analysis, no signiﬁcant difference was found be-
tween the EVAR and OSR groups for 30-day mortality
(35.4% and 37.4%, respectively), but there was a signiﬁcant
number of protocol variations (11%). In the endovascular
ﬁrst strategy group, patients who were actually treated by
EVAR (n ¼ 150) had a 30-day mortality of 25% compared
with 37% for those treated in the OSR ﬁrst strategy group
(n ¼ 220), results similar to those obtained in our study
(24% and 40%, respectively). Subgroup analysis revealed a
survival beneﬁt for women treated with EVAR. After EVAR,
patients had a shorter stay in hospital than OSR patients,
and the costs related to both groups of patients after 30
days was comparable. They also found that the lowest
measured systolic blood pressure was an independent risk
factor for 30-day mortality, and that the use of local anes-
thesia during EVAR reduced the 30-day mortality. In this
study shock and use of local anesthesia had no effect on
mortality after EVAR.In contrast to published randomized trials, retrospective
data are generally more favorable for EVAR. Inclusion of
symptomatic non-ruptured aneurysms in retrospective se-
ries could contribute to this difference between trials and
retrospective studies. To avoid such a bias in our study, we
individually assessed the presence of true rupture in all
cases. Veith19 has published collected data from 49 in-
stitutions that routinely use EVAR for the treatment of
rAAA. One thousand and thirty-seven patients treated by
EVAR and 763 patients treated by OSR were included in the
review. The study showed a signiﬁcant reduction in early
mortality favoring EVAR (21% vs. 36%, p < .001). The author
concluded that EVAR is superior to OSR for patients with
suitable anatomy, especially those who are more hemody-
namically unstable, which is in line with the ﬁndings in this
study. A population-based study by Mandawat et al.20
showed that EVAR is superior to OSR in regard to short-
term clinical outcomes (36% vs. 18%, p < .01). Nedeau
et al.21 published a retrospective study comparing EVAR
with OSR. Although their patient sample was smaller than
in this study (19 EVAR and 55 OSR patients), their conclu-
sions were very similar, with EVAR conferring an early and
mid-term survival beneﬁt. A recent publication by Mehta
et al.22 also compared early mortality for EVAR versus OSR
in rAAA patients.22 In a sample of 283 patients, of whom
120 underwent EVAR, the authors reached a similar
conclusion regarding an early mortality beneﬁt for EVAR,
which was maintained over time. However, the study by
Mehta et al.22 found a higher risk for EVAR in elderly pa-
tients, which was only present for OSR in this study. In
addition to survival analysis, more insight is provided into
the complications after rAAA, suggesting important differ-
ences on the number and type of complications found after
OSR and EVAR.
A low Hgb level on admission was associated with adverse
early prognosis after rAAA. This seems logical, as it suggests
more extensive bleeding and a more prolonged evolution,
increasing the chance of cardiac ischemia due to inadequate
oxygen delivery.This is potentially aggravated by the fact that
OSR is associated with greater blood loss. Age more than 75
years was associated with a higher risk of early death after
OSR, but not after EVAR. This could be the result of reduced
physiological reserve in elderly patients, which is insufﬁcient
to withstand the added insult of open surgery. Similarly, the
presence of shock on admission was an independent
Figure 2. Thirty-day mortality and relative amount of open surgical repair (OSR)- or endovascular aneurysm repair (EVAR)-treated patients.
484 G.C.I. von Meijenfeldt et al.predictor for early outcome after OSR, but not after EVAR.
This interesting observation may be explained by the less
invasive nature of EVAR and the maintenance of higher pe-
ripheral resistance during endovascular operations. Another
interesting observation is that coagulopathy on admission
was associated with increased mortality after EVAR, but not
after OSR. Although this could not be tested for confounders,
it may be explained by persistent bleeding followed by
abdominal compartment syndrome, and by a higher
threshold for transfusion after EVAR.
The difference in early survival could also be explained by
patient selection prior to the operation.22 A common
argument is that the most unstable patients would notTable 4. Postoperative complications.
Variable OSR EVAR p
Days in ICU, median (IQR) 4 (1e11) 1 (1e5) .001
Total days of admission,
median (IQR)
14 (6e33) 8.5 (4e21) .001
Major complications 95 (76) 46 (58) .007
Systemic complications 80 (64) 42 (53) .124
Cardiac 20 (16) 8 (10)
Cerebrovascular 6 (5) 3 (4)
Renal 49 (39) 25 (32)
Pulmonary 33 (26) 18 (23)
Local complications 38 (30) 12 (19) .070
Bowel ischemia 13 (10) 2 (3)
Abdominal
compartment syndrome
10 (8) 4 (5)
Bleeding 7 (6) 1 (1)
Distal embolization/
thrombosis
5 (4) 1 (1)
Wound infection 9 (7) 1 (1)
Graft-related 3 (2) 5 (6)
Multiple complications 52 (42) 19 (24) .047
Fatal complications 37 (30) 11 (16) .033
Note. OSR ¼ open surgical repair; EVAR ¼ endovascular aneurysm
repair; ICU ¼ intensive care unit; IQR ¼ interquartile range.undergo a CTA and, as a consequence, not be offered EVAR.
In our population, however, admission hemodynamic status
was similar for both groups, and the presence of shock was
only found to inﬂuence outcome after OSR. It could be
argued that the difference of admission time suggests that
OSR patients are more unstable as theirs is shorter. We
think that this difference is mainly due to the need for CTA
in EVAR patients and not directly to patients’ hemodynamic
status. Furthermore, admission information was missing
16.7% of the data, which makes it less reliable than the
shock index (<3%). These ﬁndings support the prior sug-
gestion by Hinchliffe et al.6 that the most unstable patients
may be the ones to obtain the greatest beneﬁt from EVAR.
Also, it is possible that anatomically suitable patients for
EVAR have a better outcome than those who are anatom-
ically unsuitable, independent of the type of repair, as
suggested by Ioannidis et al.23 and Dick et al.24 However,
this effect was not observed in a study by Ten Bosch et al.,25
in which anatomical suitability did not inﬂuence results in a
cohort of patients who all underwent preoperative CTA
irrespective of hemodynamic status. We could not conﬁrm
the hypothesis of anatomical suitability because some pa-
tients undergoing OSR did not undergo a preoperative CTA,
and performing this analysis would inevitably incur bias.
However, no supra-renal or type IV thoraco-abdominal
aneurysm patients were included in our series.
Postoperatively, the total admission period and ICU
period for patients treated with EVAR was signiﬁcantly
lower than that of OSR-treated patients. This suggests a
quicker recovery and less severe postoperative complica-
tions for EVAR. In parallel with mortality, EVAR was asso-
ciated with a threefold reduction in the risk of major
complications, and the occurrence of multiple and fatal
complications were more frequent after OSR, contributing
to better early survival rates for EVAR.
Over time, the prognosis of patients treated with EVAR
gradually converged with that of OSR patients. In this series,
Figure 3. KaplaneMeier curve of survival after ruptured abdominal
aortic aneurysm repair, by type of repair (log rank p ¼ .52). Note.
OSR ¼ open surgical repair; EVAR ¼ endovascular aneurysm
repair.
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this point, the survival of the two groups was similar. No
clear explanation for this effect could be found, but it is
hypothesized that it may reﬂect the less aggressive nature
of EVAR, therefore minimizing the “second hit” after
rupture. In patients with severe comorbidities, the addi-
tional surgical aggression of OSR could result in early death.
Similarly, frail patients may survive the acute period after
EVAR, but succumb to their comorbidities at mid-term. We
found no evidence that EVAR-related complications could
explain the observed pattern.
The results of this study are limited by the retrospective
design and individualized treatment selection, which could
result in bias. Also, the time span of the study may have
inﬂuenced results, with inevitable management and referral
modiﬁcations occurring over time. For the outcome anal-
ysis, year of operation was used as a co-variable, therefore
adjusting for this potential confounder. Because of the
relatively small sample, and because many patients died
very early after the start of follow-up owing to the rupture,
there was not sufﬁcient statistical power to determine dif-
ferences in long-term survival, and restricted the analysis to
4 years after repair. Finally, accurate turn-down rates for
repair, which are known to signiﬁcantly inﬂuence the overall
survival after rAAA, could not be provided. This important
limitation probably has less impact on direct comparisonbetween treatment modalities than on the overall results of
rAAA repair.
In conclusion, this study shows a twofold early mortality
risk reduction for rAAA patients undergoing EVAR, which is
maintained over the mid-term. Old age and the presence of
shock were signiﬁcant predictors of early mortality for OSR
only, suggesting that EVAR may be particularly beneﬁcial for
patients presenting with these factors.26 Also, OSR patients
were at higher risk of major postoperative complications,
required longer ICU and hospital stays, and appeared more
likely to suffer from multiple and fatal complications after
surgery. These results support the preferential use of EVAR
for rAAA, and suggest a potential improvement in risk
prediction by introducing the type of repair into the
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